THEMIS trial showed significant reduction of ischaemic events in patients with stable CAD and type 2 diabetes using the combination of ticagrelor and aspirin, compared with aspirin alone. Deepak L. Bhatt (Brigham and Women’s Hospital, Harvard Medical School, Boston) summarises for us the key points of the trial at the ESC 2019 congress.